Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Hooker Furnishings to Host Second Quarter Earnings Call September 11th
-
Inventronics Announces 2026 Q2 Financial Results
-
McEwen Copper Completes US$240 Million Term Loan to Advance Los Azules Toward Final Investment Decision
-
Premium Global Income Split Corp. Announces Semi-Annual Results
-
LeMaitre to Participate at Upcoming Investor Conferences in September
-
Mulvihill Premium Yield Fund Announces Semi-Annual Results
-
Mulvihill Enhanced Split Preferred Share ETF Announces Semi-Annual Results
-
FDA Approves First Targeted Therapy for Dermatomyositis
-
Mulvihill Canadian Bank Enhanced Yield ETF Announces Semi-Annual Results
-
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
-
Red River Bancshares, Inc. Announces Quarterly Cash Dividend
-
ARRAY Technologies to Participate in Upcoming Investor Conferences
-
Capital Southwest Announces Quarterly Regular Dividend for the Quarter Ending December 31, 2026 and Quarterly Supplemental Dividend Payable on December 31, 2026
-
Alamos Gold Declares Quarterly Dividend
-
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
-
Exascale Labs Holdings Inc. Announces Closing of Business Combination with D. Boral ARC Acquisition I Corp. and Commencement of Trading on Nasdaq Under Ticker Symbol “XLAB”
-
Canadian Red Cross launches appeal to support people impacted by the devastating flash floods in Nepal
-
Stifel Reports July 2026 Operating Data
-
Quanex Building Products Declares Quarterly Dividend
-
ARMOUR Residential REIT, Inc. Announces September 2026 Dividend Rate Per Common Share
-
IBEX Limited to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 10, 2026
-
Founder Group Limited Announces 100 for 1 Share Combination
-
Pasqal Announces the Board of Directors of the Combined Company Following Its Nasdaq Listing
-
Capital City Bank Group, Inc. Announces Cash Dividend
-
Alerus Financial Corporation Declares Cash Dividend on Common Shares and Announces New Stock Repurchase Program
-
IREN Reports FY26 Results
-
Victory Springs Phase One Development at Table Rock Lake Ready to Begin
-
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026
-
Zumiez Inc. to Report Fiscal 2026 Second Quarter Results
-
First Watch Restaurant Group, Inc. to Participate in Two September Investor Conferences
-
Root Reduces Auto Insurance Rates by 15% in Florida, Citing Impact of Legal Reforms
-
Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™
-
Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference
-
Parsons Strengthens Leadership in Global Counter-Nuclear Smuggling Mission with Two New NNSA Task Orders
-
Applied Materials Appoints Akash Palkhiwala to Board of Directors
-
Pulmonx to Participate in Upcoming Investor Conferences
-
Vaxcyte to Participate in Upcoming Investor Conferences
-
Nutanix to Present at Upcoming Investor Conference
-
Pasqal and Bleichroeder Acquisition Corp. II Complete Business Combination
-
Key Tronic Corporation Announces Results for the Fourth Quarter and Year End of Fiscal 2026
-
Asure Celebrates 50 Small and Mid-Sized Business Honorees at 2026 Asure50 Awards
-
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
-
WTW Announces Regular Quarterly Dividend
-
Music Beats Cancer Launches “Thumbs Up for a Cure” to Support the Next Generation of Childhood Cancer Treatments
-
PruittHealth Celebrates Senior CNA Graduates at Walt Disney World® Resort
-
Novarad Updates NovaPACS EI Customers Worldwide to 9.1, a Major Security Upgrade
-
Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project
-
Scripps taps NBCU sales veteran to lead small and medium business growth and direct response advertising
-
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
-
Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
